Original news and analysis on international IP policy
By William New In an unusual policy for an international organisation, the World Customs Organization imposes copyright over every document its bodies produce, even agendas, which means that no document can be reproduced without the organisation’s express consent. But now…
By Bruce Gain for Intellectual Property Watch
An upcoming federal court ruling in the United States that will determine whether or not RealNetworks' RealDVD copying software violates the US Digital Millennium Copyright Act (DMCA) will likely have a major impact on releases of similar software in the near future.
By Kaitlin Mara Work of the World Intellectual Property Organisation body dedicated to the protection of traditional knowledge and folklore this week has moved largely to informal meetings after progress in the full plenary sessions over the first few days…
By William New Whether the World Trade Organization director general position will be up for grabs in the new year remains a question, as current DG Pascal Lamy is deciding by December whether to run for the post again. Meanwhile,…
By Catherine Saez President Bush on Monday signed into law a bill strengthening civil and criminal laws against counterfeiting and piracy, boosting resources for enforcement and prosecution, and changing coordination of IP enforcement issues within the Executive Branch. Under the…
By Liza Porteus Viana for Intellectual Property Watch WASHINGTON, DC – There is a growing backlash against intellectual property rights and international rules aimed at protecting innovation and ideas in certain parts of the globe, several pharmaceutical and other innovator…
By William New The leaders of the powerful United States Senate Judiciary Committee on Thursday warned US trade negotiators to rein in the scope of negotiations on an international treaty against counterfeiting, and to make the process more transparent. At…
A much-heralded 2003 waiver to World Trade Organization intellectual property rules aimed at helping poor countries receive needed medicines they cannot produce themselves has brought little if any help five years later, according to governments and public health advocates. The…
By Liza Porteus Viana for Intellectual Property Watch In the waning days of this congressional session in the United States, US lawmakers are passing a flurry of intellectual property-related bills. One of the bills awaiting President Bush’s signature would create…
By Liza Porteus Viana for Intellectual Property Watch
When the new administration and Congress come into office following the November elections in the United States, the pharmaceutical and biotechnology industries will prioritise protection of their intellectual property and innovative biological drugs as the push for cheaper, generic versions gets stronger. Patent reform also will continue to be a lobbying priority, as well as making sure intellectual property is protected in any forthcoming international trade agreements.